Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
Apr 11 2022
BUY
Open market or private purchase
$6,802,999 $1.9 p/Share
3,580,526
Oct 18 2021
BUY
Open market or private purchase
-
1,851,852

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on TRVI

Follow Trevi Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

News

Receive news related to Trevi Therapeutics, Inc.

Track Activities on TRVI